DD298052A5 - Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen - Google Patents

Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen Download PDF

Info

Publication number
DD298052A5
DD298052A5 DD90344186A DD34418690A DD298052A5 DD 298052 A5 DD298052 A5 DD 298052A5 DD 90344186 A DD90344186 A DD 90344186A DD 34418690 A DD34418690 A DD 34418690A DD 298052 A5 DD298052 A5 DD 298052A5
Authority
DD
German Democratic Republic
Prior art keywords
alkylamino
group
alkyl
propyl
halogen
Prior art date
Application number
DD90344186A
Other languages
German (de)
English (en)
Inventor
Hans Joerg Eibl
Clemens Unger
Juergen Engel
Original Assignee
Asta-Pharma Aktiengesellschaft,De
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E. V.,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD298052(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta-Pharma Aktiengesellschaft,De, Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E. V.,De filed Critical Asta-Pharma Aktiengesellschaft,De
Publication of DD298052A5 publication Critical patent/DD298052A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD90344186A 1989-09-27 1990-09-25 Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen DD298052A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (1)

Publication Number Publication Date
DD298052A5 true DD298052A5 (de) 1992-02-06

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90344186A DD298052A5 (de) 1989-09-27 1990-09-25 Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen

Country Status (17)

Country Link
EP (2) EP0916343A1 (xx)
JP (1) JP3176615B2 (xx)
CA (1) CA2026278C (xx)
DD (1) DD298052A5 (xx)
DE (1) DE4029747C2 (xx)
EG (1) EG19338A (xx)
FI (1) FI904726A0 (xx)
HU (1) HU209589B (xx)
IE (1) IE903464A1 (xx)
LT (1) LT3804B (xx)
LV (1) LV10391B (xx)
MC (1) MC2150A1 (xx)
NO (1) NO904184L (xx)
PT (1) PT95422B (xx)
RU (1) RU1837877C (xx)
UA (1) UA19335A (xx)
ZA (1) ZA907702B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
EP1051159B1 (en) * 1998-01-22 2002-04-10 Zentaris AG Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
AU2009349348B2 (en) * 2009-07-09 2014-09-11 Paul Meng Liquid pharmaceutical form of alkylphosphocholine and method of preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1280369C (en) * 1985-12-04 1991-02-19 Hansjorg Eibl Pharmaceutical with anti-tumor effect
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
MC2150A1 (fr) 1992-03-10
PT95422A (pt) 1991-05-22
ZA907702B (en) 1991-07-31
DE4029747C2 (de) 2003-10-02
FI904726A0 (fi) 1990-09-26
EP0419998A3 (en) 1991-10-23
EP0419998A2 (de) 1991-04-03
NO904184D0 (no) 1990-09-26
JPH03130228A (ja) 1991-06-04
JP3176615B2 (ja) 2001-06-18
IE903464A1 (en) 1991-04-10
PT95422B (pt) 1997-07-31
RU1837877C (ru) 1993-08-30
LT3804B (en) 1996-03-25
NO904184L (no) 1991-04-02
CA2026278A1 (en) 1991-03-28
CA2026278C (en) 1996-04-30
LV10391B (en) 1995-10-20
HU906233D0 (en) 1991-03-28
UA19335A (uk) 1997-12-25
EG19338A (en) 1994-12-30
LV10391A (lv) 1995-02-20
HU209589B (en) 1994-08-29
LTIP1488A (en) 1995-06-26
HUT55992A (en) 1991-07-29
DE4029747A1 (de) 1991-04-11
EP0916343A1 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
DE3336047C2 (de) Topisch applizierbare pharmazeutische Zusammensetzung mit dem Wirkstoff Diclofenac
EP0467164B1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
EP0241809B1 (de) Synergistische Kombination von Amantadin und Selegilin
DE4035442B4 (de) Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure
EP0248062B1 (de) Arzeimittel
EP0533213B1 (de) Verwendung des Wirkstoffs Azelastin und Glycerinethern zur Bekämpfung von Psoriasis-Erkrankungen
DE4218572A1 (de) Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DD291925A5 (de) Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
EP0180785A1 (de) Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung
EP0193056A1 (de) Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
EP0369263A2 (de) Präparate zur topischen Behandlung von Hautkrankheiten
EP0277352B1 (de) Synergistische Kombination von Azelastin und Theophyllin oder Azelastin und Beta-Mimetika
DD298052A5 (de) Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen
EP0269899A2 (de) Verwendung von aromatischen Carbonsäureamiden
DE69121551T2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE69023045T2 (de) Carboxamidderivate.
EP0159519A2 (de) Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
DE69307197T2 (de) Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis
DE4331168A1 (de) Kombination von N-Acetyl-p-Aminophenol mit schwefelenthaltenden Carbonsäuren, wie z. B. alpha-Liponsäure und deren Derivate, zur Bekämpfung von Schmerzzuständen
DE3710966A1 (de) Synergistische kombination von amantadin und selegilin
DE3406837A1 (de) Arteriosklerose-arzneimittel und -prophylaktikum
EP0006435A1 (de) Arzneimittelkombination zur Behandlung von Durchblutungsstörungen und Verfahren zu ihrer Herstellung
DE3509071A1 (de) Verwendung von thioverbindungen zur verhinderung des durch cytostatika verursachten haarausfalls
DE2502678A1 (de) Arzneimittel zur behandlung primaerer und sekundaerer hyperlipoproteinaemien und verfahren zu seiner herstellung
DE3027639A1 (de) Verwendung von substituierten acetaniliden als arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee